Treatment of Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes

被引：0
作者：
Courson, Alesa [1 ]
Twilla, Jennifer D. [1 ]
Hara, Jayme [1 ]
Jones, G. Morgan [1 ]
机构：
[1] Methodist Univ Hosp, Memphis, TN USA
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1378
引用
收藏
页码：878A / 878A
页数：1
相关论文
共 50 条
  • [41] Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin
    Seifert, Leon Louis
    Schindler, Philipp
    Schoster, Martin
    Weller, Jan Frederic
    Wilms, Christian
    Schmidt, Hartmut H.
    Maschmeier, Miriam
    Masthoff, Max
    Koehler, Michael
    Heinzow, Hauke
    Wildgruber, Moritz
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [42] Emergency Department Utilization in Patients With Hepatic Encephalopathy (HE) Treated With Rifaximin (± Lactulose) versus Lactulose Alone
    Volk, Michael
    Burne, Rebecca
    Guerin, Annie
    Shi, Sherry
    Joseph, George
    Heimanson, Zeev
    Ahmad, Maliha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S539 - S539
  • [43] Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Lise Lotte Gluud
    Gitte Dam
    Mette Borre
    Iñigo Les
    Juan Cordoba
    Giulio Marchesini
    Niels Kristian Aagaard
    Hendrik Vilstrup
    Metabolic Brain Disease, 2013, 28 : 221 - 225
  • [44] Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Gluud, Lise Lotte
    Dam, Gitte
    Borre, Mette
    Les, Inigo
    Cordoba, Juan
    Marchesini, Giulio
    Aagaard, Niels Kristian
    Vilstrup, Hendrik
    METABOLIC BRAIN DISEASE, 2013, 28 (02) : 221 - 225
  • [45] Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
    Wang, Zhida
    Chu, Pei
    Wang, Wenjin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1 - 11
  • [46] Clinical effects of rifaximin in patients with hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study
    Sama, C
    Morselli-Labate, AM
    Pianta, P
    Lambertini, L
    Berardi, S
    Martini, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (05): : 413 - 422
  • [47] Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
    Hudson, Mark
    Schuchmann, Marcus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) : 434 - 450
  • [48] Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
    Ridola, Lorenzo
    Zullo, Angelo
    Hassan, Cesare
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (01) : 56 - 56
  • [49] Cost Effectiveness of Rifaximin in the Treatment of Hepatic Encephalopathy
    Congly, Stephen E.
    Leise, Michael D.
    Kim, W. Ray
    HEPATOLOGY, 2013, 58 : 869A - 869A
  • [50] A Comparison of Rifaximin with Placebo for the treatment of Hepatic Encephalopathy
    Majeed, Abida
    Butt, Mishal Waheed
    Aziz, Hafiza Ayesha
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (01): : 362 - 364
12345